PI11528 (R)-(-)-3-Carbamoymethyl-5-methylhexanoic acid (CAS No.: 181289-33-8)

(R)-(-)-3-Carbamoymethyl-5-methylhexanoic acid (CAS No.: 181289-33-8) Description

(R)-(-)-3-Carbamoymethyl-5-methylhexanoic acid, with a molecular formula of C9H17NO3, is employed as a key intermediate in pharmaceutical synthesis. The compound's defined chemical structure enables precise reaction control in multi-step syntheses. Its powder form supports accurate measurement and integration into reaction mixtures, providing an essential component in chemical production processes where dosage accuracy and purity are critical.

(R)-(-)-3-Carbamoymethyl-5-methylhexanoic acid (CAS No.: 181289-33-8) Applications

1.         Pharmaceutical Manufacturing
- Used as a reactive intermediate in drug synthesis to enhance formulation precision by utilising its consistent chemical composition.
- Applied as a precursor in developing active pharmaceutical ingredients to achieve targeted reaction outcomes with controlled impurity profiles.

2.         Industrial Synthesis
- Serves as a component in specialty chemical production to obtain specific reaction pathways by capitalising on its reproducible reactivity.
- Frequently used for method development in chemical research to refine process efficiencies and minimise unwanted by-products.

(R)-(-)-3-Carbamoymethyl-5-methylhexanoic acid (CAS No.: 181289-33-8) Packing

The compound is packaged in moisture-resistant, airtight containers to protect against environmental exposure. Packaging materials include inert plastic liners and corrugated cartons that provide mechanical protection. Storage recommendations emphasise a cool, dry, and contamination-free environment. Custom packaging options are available to meet specific laboratory and production shipping requirements, facilitating safe handling and optimal product integrity.

Additional Information

Pharmaceutical intermediates such as (R)-(-)-3-Carbamoymethyl-5-methylhexanoic acid are critical components in the synthesis of complex therapeutic agents. Their production involves precise chemical engineering processes to obtain purity and reproducibility. Understanding the compound's role in multi-step synthetic pathways helps researchers optimise reaction conditions and improve overall yields.

Advancements in chemical synthesis and quality control have led to improved manufacturing processes for pharmaceutical ingredients. The integration of analytical techniques, such as HPLC and mass spectrometry, ensures that each batch meets defined specifications, thereby enhancing process reliability and compliance with regulatory standards.